22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Efforts are underway to transform regulatory toxicology and chemical safety assessment from a largely empirical science based on direct observation of apical toxicity outcomes in whole organism toxicity tests to a predictive one in which outcomes and risk are inferred from accumulated mechanistic understanding. The adverse outcome pathway (AOP) framework provides a systematic approach for organizing knowledge that may support such inference. Likewise, computational models of biological systems at various scales provide another means and platform to integrate current biological understanding to facilitate inference and extrapolation. We argue that the systematic organization of knowledge into AOP frameworks can inform and help direct the design and development of computational prediction models that can further enhance the utility of mechanistic and in silico data for chemical safety assessment. This concept was explored as part of a workshop on AOP-Informed Predictive Modeling Approaches for Regulatory Toxicology held September 24–25, 2015. Examples of AOP-informed model development and its application to the assessment of chemicals for skin sensitization and multiple modes of endocrine disruption are provided. The role of problem formulation, not only as a critical phase of risk assessment, but also as guide for both AOP and complementary model development is described. Finally, a proposal for actively engaging the modeling community in AOP-informed computational model development is made. The contents serve as a vision for how AOPs can be leveraged to facilitate development of computational prediction models needed to support the next generation of chemical safety assessment.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

          Ecological risk assessors face increasing demands to assess more chemicals, with greater speed and accuracy, and to do so using fewer resources and experimental animals. New approaches in biological and computational sciences may be able to generate mechanistic information that could help in meeting these challenges. However, to use mechanistic data to support chemical assessments, there is a need for effective translation of this information into endpoints meaningful to ecological risk-effects on survival, development, and reproduction in individual organisms and, by extension, impacts on populations. Here we discuss a framework designed for this purpose, the adverse outcome pathway (AOP). An AOP is a conceptual construct that portrays existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment. The practical utility of AOPs for ecological risk assessment of chemicals is illustrated using five case examples. The examples demonstrate how the AOP concept can focus toxicity testing in terms of species and endpoint selection, enhance across-chemical extrapolation, and support prediction of mixture effects. The examples also show how AOPs facilitate use of molecular or biochemical endpoints (sometimes referred to as biomarkers) for forecasting chemical impacts on individuals and populations. In the concluding sections of the paper, we discuss how AOPs can help to guide research that supports chemical risk assessments and advocate for the incorporation of this approach into a broader systems biology framework.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adverse outcome pathway (AOP) development I: strategies and principles.

            An adverse outcome pathway (AOP) is a conceptual framework that organizes existing knowledge concerning biologically plausible, and empirically supported, links between molecular-level perturbation of a biological system and an adverse outcome at a level of biological organization of regulatory relevance. Systematic organization of information into AOP frameworks has potential to improve regulatory decision-making through greater integration and more meaningful use of mechanistic data. However, for the scientific community to collectively develop a useful AOP knowledgebase that encompasses toxicological contexts of concern to human health and ecological risk assessment, it is critical that AOPs be developed in accordance with a consistent set of core principles. Based on the experiences and scientific discourse among a group of AOP practitioners, we propose a set of five fundamental principles that guide AOP development: (1) AOPs are not chemical specific; (2) AOPs are modular and composed of reusable components-notably key events (KEs) and key event relationships (KERs); (3) an individual AOP, composed of a single sequence of KEs and KERs, is a pragmatic unit of AOP development and evaluation; (4) networks composed of multiple AOPs that share common KEs and KERs are likely to be the functional unit of prediction for most real-world scenarios; and (5) AOPs are living documents that will evolve over time as new knowledge is generated. The goal of the present article was to introduce some strategies for AOP development and detail the rationale behind these 5 key principles. Consideration of these principles addresses many of the current uncertainties regarding the AOP framework and its application and is intended to foster greater consistency in AOP development.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference.

              The biotechnological advances of the last decade have confronted us with an explosion of genetics, genomics, transcriptomics, proteomics, and metabolomics data. These data need to be organized and structured before they may provide a coherent biological picture. To accomplish this formidable task, the availability of an accurate map of the physical interactions in the cell that are responsible for cellular behavior and function would be exceedingly helpful, as these data are ultimately the result of such molecular interactions. However, all we have at this time is, at best, a fragmentary and only partially correct representation of the interactions between genes, their byproducts, and other cellular entities. If we want to succeed in our quest for understanding the biological whole as more than the sum of the individual parts, we need to build more comprehensive and cell-context-specific maps of the biological interaction networks. DREAM, the Dialogue on Reverse Engineering Assessment and Methods, is fostering a concerted effort by computational and experimental biologists to understand the limitations and to enhance the strengths of the efforts to reverse engineer cellular networks from high-throughput data. In this chapter we will discuss the salient arguments of the first DREAM conference. We will highlight both the state of the art in the field of reverse engineering as well as some of its challenges and opportunities.
                Bookmark

                Author and article information

                Journal
                Toxicol Sci
                Toxicol. Sci
                toxsci
                Toxicological Sciences
                Oxford University Press
                1096-6080
                1096-0929
                February 2017
                19 December 2016
                19 December 2016
                : 155
                : 2
                : 326-336
                Affiliations
                [a ]European Commission, Joint Research Centre, Ispra 21027, Italy;
                [b ]Bulgarian Academy of Sciences, Sofia 1113, Bulgaria;
                [c ]US Environmental Protection Agency, Duluth, Minnesota 55804;
                [d ]FOCAS Research Institute, Dublin 8, Ireland;
                [e ]National Institute for Public Health and the Environment (RIVM), Bilthoven, MA 3721, The Netherlands;
                [f ]Universität des Saarlandes, 66123 Saarbrücken, Germany;
                [g ]Johannes Kepler Universität, Linz 4040, Austria;
                [h ]Unilever Safety and Environmenta Assurance Centre, Sharnbrook, MK44 1LQ, UK;
                [i ]University of Ottawa, Ontario K1N 6N5, Canada
                [j ]US Army Engineer Research and Development Center, Vicksburg, Mississippi 39180;
                [k ]European Chemicals Agency, ECHA, 00121 Helsinki, Finland;
                [l ]Pacific Northwest National Laboratory, Richland, Washington 99352
                Author notes
                [1 ]To whom correspondence should be addressed at European Commission, Joint Research Centre, Via E. Fermi 2749 – TP 126, Ispra 21027, Italy. E-mail: clemens.wittwehr@ 123456ec.europa.eu .
                Article
                kfw207
                10.1093/toxsci/kfw207
                5340205
                27994170
                f6e1e7fa-83c5-497f-9ede-0ecf0ad49229
                © The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                Page count
                Pages: 11
                Funding
                Funded by: the European Commission's Joint Research Centre (JRC)
                Categories
                Forum: AOPs, Computational Models, and Regulatory Toxicity
                Custom metadata
                corrected-proof

                Pharmacology & Pharmaceutical medicine
                adverse outcome pathways,aop,quantitative aop,computational prediction model.

                Comments

                Comment on this article